The Arizona Poison and Drug Information Center at the R. Ken Coit College of Pharmacy and the Arizona Dispensaries Association are teaming up to combat a growing number of accidental marijuana intakes, especially among children.

A compound developed by researchers at the R. Ken Coit College of Pharmacy moves one step closer to commercialization with licensing agreement.

An article about alternative medicine infiltrating mainstream health care mentions the research of Gary Schwartz, professor of psychology in the UArizona College of Science with additional appointments in the College of Medicine – Tucson.

Researchers at the R. Ken Coit College of Pharmacy have been developing and measuring the effectiveness of a new compound that inhibits SARS-CoV-2, the virus that causes COVID-19, and the university has exclusively licensed the technology to Sunshine Biopharma Inc. to take the technology forward for further development and testing.

Ivo Abraham, PhD, professor of practice in the R. Ken Coit College of Pharmacy, details how biosimilar guidelines from the World Health Organization have changed over time and whether those changes are beneficial for biosimilars.

Stricter rules for patients and doctors who use telemedicine could soon become reality. The DEA recently proposed rules that would require patients to see a doctor in person before they could receive treatment for an attention deficit disorder or be prescribed things like painkillers.

The University of Arizona Health Sciences Primary Care Physician Scholarship program is designed to fill Arizona’s increasing need for primary care providers.

The goal of the conference is to improve patient outcomes by sharing knowledge with primary care providers and others interested in mental health concerns.

UArizona football alumnus and four-time Super Bowl champion Rob Gronkowski has committed $1 million to help pets fight Valley fever. The funding will allow pharmaceutical company Anivive, which has also teamed up with researchers at the UArizona Valley Fever Center for Excellence, to commercialize its Valley fever vaccine for dogs.